PROBIOTIX HEALTH LS-05

Research PROBIOTIX HEALTH LS-05 (X90) on Bullrun: market cap EUR 16.17M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 16.17M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2024GBP 1.88M-GBP 847.00K-GBP 1.07M52.9%-0.01GBP 1.65Mn/aGBP 1.92M
FY2023GBP 1.67M-GBP 747.00K-GBP 238.00K52.1%-0.01GBP 1.50Mn/aGBP 1.53M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-08EUR 16.17Mn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 EUR.

About PROBIOTIX HEALTH LS-05

ProBiotix Health Plc develops probiotics to tackle cardiovascular disease and other lifestyle conditions in the United Kingdom, the United States, and internationally. The company offers YourBiotixMH for menopause health; YourBiotixCH InstaMelt and YourBiotixCH for cholesterol maintenance; and YourBiotixX3 for cholesterol reduction. It also provides YourBiotixBP for blood pressure reduction; and YourBiotixVH for vascular health support.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is PROBIOTIX HEALTH LS-05's market cap?

PROBIOTIX HEALTH LS-05's market capitalization is EUR 16.17M.

What does PROBIOTIX HEALTH LS-05 do?

ProBiotix Health Plc develops probiotics to tackle cardiovascular disease and other lifestyle conditions in the United Kingdom, the United States, and internationally. The company offers YourBiotixMH for menopause health; YourBiotixCH InstaMelt and YourBiotixCH for cholesterol maintenance; and YourBiotixX3 for cholesterol reduction. It also provides YourBiotixBP for blood pressure reduction; and YourBiotixVH for vascular health support. The company was formerly known as ProBiotix Health Limited and changed its name to ProBiotix Health Plc in February 2022.